StockNews.com Initiates Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC)
StockNews.com began coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a research report report published on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Trading Up 6.8 % Shares of Cyclacel Pharmaceuticals stock opened at $0.32 on Friday. The business has a 50-day moving average price […]
StockNews.com began coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a research report report published on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Trading Up 6.8 % Shares of Cyclacel Pharmaceuticals stock opened at $0.32 on Friday. The business has a 50-day moving average price […]
